e-therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
General Public | 31,986,085 | 5.47% |
Private Companies | 34,713,630 | 5.94% |
Institutions | 216,286,302 | 37% |
Individual Insiders | 301,349,470 | 51.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
169,885,905 | US$22.1m | 0% | no data | |||
101,825,000 | US$13.2m | 0% | 0.03% | |||
51,550,000 | US$6.7m | -0.87% | no data | |||
50,941,666 | US$6.6m | 0% | no data | |||
27,969,630 | US$3.6m | -6.05% | no data | |||
27,178,003 | US$3.5m | 0% | no data | |||
13,900,000 | US$1.8m | -2.55% | no data | |||
10,742,103 | US$1.4m | 0% | 3.08% | |||
9,950,000 | US$1.3m | 1.02% | 1.1% | |||
9,178,333 | US$1.2m | 0% | 3.92% | |||
8,203,000 | US$1.1m | -0.29% | 0.01% | |||
7,000,000 | US$910.0k | -7.85% | 100.0% | |||
6,744,000 | US$876.7k | 0% | no data | |||
5,386,938 | US$700.3k | 15.6% | 0.05% | |||
4,568,509 | US$593.9k | 151% | 0.02% | |||
4,434,335 | US$576.5k | 2.86% | 0.07% | |||
4,374,999 | US$568.7k | 0% | no data | |||
4,017,603 | US$522.3k | 21.4% | no data | |||
3,830,459 | US$498.0k | 7.5% | no data | |||
2,933,497 | US$381.4k | 13.5% | no data | |||
2,837,452 | US$368.9k | 15.7% | no data | |||
2,437,773 | US$316.9k | -10.2% | 0.02% | |||
2,377,431 | US$309.1k | 871% | 0.31% | |||
2,160,350 | US$280.8k | 0% | 2.72% | |||
1,975,770 | US$256.8k | 4.31% | no data |